10X Genomics Inc (NASDAQ:TXG)
| 63.41 Delayed Data As of Dec 06 |  +0.80 / +1.28%Today’s Change | 45.11 Today|||52-Week Range 68.36 | -- Year-to-Date |
Latest TXG News | Press Releases
No recent news for 10X Genomics Inc.
Today’s Trading
| Previous close | 62.61 |
| Today’s open | 62.69 |
| Day’s range | 61.51 - 63.90 |
| Volume | 131,800 |
| Average volume (3 months) | 384,986 |
| Market cap | $6.0B |
Data as of 4:00pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | -499.44% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +105.83% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $146.3M |
| Annual profit (last year) | -$112.5M |
| Net profit margin | -76.88% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
